Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Solifenacin succinate (YM905) is a quinuclidine and tetrahydroisoquinoline derivative and selective M3 MUSCARINIC ANTAGONIST. It is used as a UROLOGIC AGENT in the treatment of URINARY INCONTINENCE.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | In stock | $ 33.00 | |
50 mg | In stock | $ 47.00 | |
100 mg | In stock | $ 89.00 | |
200 mg | In stock | $ 121.00 | |
500 mg | In stock | $ 196.00 | |
1 g | In stock | $ 289.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 29.00 |
Description | Solifenacin succinate (YM905) is a quinuclidine and tetrahydroisoquinoline derivative and selective M3 MUSCARINIC ANTAGONIST. It is used as a UROLOGIC AGENT in the treatment of URINARY INCONTINENCE. |
In vivo | Solifenacin succinate is a novel muscarinic antagonist indicated for the treatment of overactive bladder syndrome. When co-administered with oxybutynin, Solifenacin effectively inhibits the mobilization of intracellular calcium mediated by muscarinic M3 receptors in isolated bladder smooth muscle cells of guinea pigs and submandibular gland cells of mice. |
Synonyms | YM905 |
Molecular Weight | 480.56 |
Formula | C23H26N2O2·C4H6O4 |
CAS No. | 242478-38-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 25 mg/mL (52.02 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Solifenacin succinate 242478-38-2 Neuroscience AChR inhibit YM905 YM-905 Muscarinic acetylcholine receptor YM 905 Inhibitor Solifenacin Solifenacin Succinate mAChR inhibitor